Dermapharm Holding SE (FRA:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
36.50
-0.70 (-1.88%)
Last updated: Apr 17, 2025

Dermapharm Holding SE Company Description

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business.

It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals.

The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology.

In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand.

It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands.

The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Dermapharm Holding SE
Country Germany
Founded 1991
Industry Pharmaceutical Preparations
Employees 3,610
CEO Hans-Georg Feldmeier

Contact Details

Address:
Lil-Dagover-Ring 7
Grünwald, 82031
Germany
Phone 49 89 6 41 86 0
Website ir.dermapharm.de

Stock Details

Ticker Symbol DMP
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 2834

Key Executives

Name Position
Hans-Georg Feldmeier Chief Executive Officer
Christof Dreibholz Chief Financial Officer
Britta Hamberger Head of Investor Relations